Director TitleAgeSince
Chairman - -
Chairman - 2012-06-27
Director/Board Member - 2012-12-23
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
-0.80%+5.16%-0.70%+12.87% 48.95B
-1.80%+14.78%+24.24%+6.35% 40.75B
+2.67%+1.48%+417.47%+629.68% 38.46B
-11.33%-1.50%+7.31%+50.26% 36.38B
+5.56%+11.70%+11.64%+51.50% 28.45B
-1.99%-2.11% - - 16.62B
-4.22%-4.37%+32.34%+128.84% 16.33B
-10.09%-3.51%-9.45%-34.63% 13.65B
-0.06%-2.81%+3.16%+10.08% 13.56B
Average -0.34%+6.06%+60.75%+106.87% 28.13B
Weighted average by Cap. +0.05%+7.20%+76.31%+127.55%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock